TALOTTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 2.087
EU - Europa 1.384
AS - Asia 452
SA - Sud America 9
AF - Africa 2
OC - Oceania 1
Totale 3.935
Nazione #
US - Stati Uniti d'America 2.080
IE - Irlanda 648
SE - Svezia 414
CN - Cina 296
IT - Italia 171
IN - India 85
SG - Singapore 48
PL - Polonia 28
FI - Finlandia 23
BE - Belgio 19
UA - Ucraina 19
DE - Germania 18
FR - Francia 14
GB - Regno Unito 13
CA - Canada 7
BR - Brasile 6
IQ - Iraq 6
VN - Vietnam 6
CZ - Repubblica Ceca 4
BG - Bulgaria 3
DK - Danimarca 3
ES - Italia 3
TR - Turchia 3
CO - Colombia 2
EG - Egitto 2
IR - Iran 2
KZ - Kazakistan 2
QA - Qatar 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
HK - Hong Kong 1
RO - Romania 1
Totale 3.935
Città #
Dublin 647
Chandler 539
Nyköping 342
Princeton 149
Dearborn 115
Beijing 112
Jacksonville 112
Medford 112
Ann Arbor 90
Des Moines 84
New York 81
Ashburn 78
Pune 70
Wilmington 41
Cambridge 35
Messina 32
Warsaw 28
Singapore 26
Jinan 25
Brussels 19
Nanjing 19
Shenyang 19
Los Angeles 15
Zhengzhou 15
Falls Church 14
Washington 13
Catania 12
Ningbo 12
Boardman 11
Hebei 11
San Mateo 11
Guangzhou 10
Hangzhou 9
Woodbridge 9
Haikou 8
Grammichele 7
Hyderabad 7
Nanchang 7
Norwalk 7
Dong Ket 6
Fuzhou 5
Lancaster 5
Redwood City 5
Seattle 5
Verona 5
Bremen 4
Brno 4
Changsha 4
Jiaxing 4
Taizhou 4
Tianjin 4
Bengaluru 3
Clifton 3
Florence 3
Gioiosa Marea 3
Hefei 3
Helsinki 3
Iowa City 3
Itu 3
Milwaukee 3
Pisa 3
Reggio Calabria 3
São Paulo 3
Taiyuan 3
Arco 2
Astana 2
Augusta 2
Basrah 2
Bello 2
Brooklyn 2
Cagliari 2
Changle 2
Clearwater 2
Gela 2
Houston 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Lyon 2
Milan 2
Monmouth Junction 2
Plovdiv 2
Redmond 2
Roda 2
San Giorgio a Cremano 2
Waterbury 2
Albolote 1
Ardabil 1
Avola 1
Ballyhaise 1
Baotou 1
Brisbane 1
Buffalo 1
Capoterra 1
Chaoyang 1
Chengdu 1
Cologne 1
Copenhagen 1
Council Bluffs 1
Dallas 1
Totale 3.105
Nome #
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 73
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 72
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 70
effetti dell'acido ialuronico sulla qualità di vita in pazienti affetti da osteoartrosi 66
Algo-dysfunctional syndromes: a critical digest of the recent literature 66
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 65
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 64
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 64
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 57
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 56
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 55
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 55
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 54
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 53
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 52
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 52
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 51
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 49
CHRONIC PAIN AND DEPRESSION: PAIN THRESHOLD AND VISUAL ANALOGUE SCALE. 48
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 48
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 47
Biomarkers in Rheumatoid Arthritis 47
Immunogenicity and autoimmunity during anti-TNF therapy 47
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 46
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 45
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 45
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 45
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 44
From autoinflammation to autoimmunity: old and recent findings 43
Autoimmunity as the comet tail of COVID-19 pandemic 43
Riniti persistenti da un punto di vista immunologico 42
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 42
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 42
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 42
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 42
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 41
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 41
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 41
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 41
Patologie respiratorie allergiche e miceti: casistica personale. 40
One year in review 2019: fibromyalgia 40
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 40
THE CORRELATION BETWEEN CTLA4, CD80 AND CD86 GENE POLYMORPHISMS AND CLINICAL RESPONSE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT. 39
Measurement of Serum Klotho in Systemic Sclerosis 39
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 39
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 39
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 39
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 38
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 38
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 38
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 37
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 37
GENISTEIN PREVENTS QUALITY OF LIFE OSTEOPENIC POST- MENOPAUSAL WOMENS: A 2-YEAR RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY. 36
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 36
PAIN INTENSITY AND THRESHOLD IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: CORRELATIONS WITH THE HAMILTON DEPRESSION RATING SCALE 36
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 35
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 35
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 35
Pain in systemic sclerosis 35
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 35
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 35
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 35
Infections and Biological Therapy in Patients with Rheumatic Diseases 33
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 33
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 33
Psoriatic arthritis: From pathogenesis to pharmacologic management 32
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 32
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 31
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 31
VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS. 30
Vitamin D levels and bone mineral density in systemic sclerosis 30
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 30
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 29
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 29
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric 28
Novel pharmaceutical options for treating fibromyalgia 27
null 26
The role of klotho in systemic sclerosis 26
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy 26
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 24
Polymorphic alleles in Exon 1 of the CTLA4 gene do not predict the response to abatacept. 23
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 23
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 23
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 23
Spondyloarthritis and Gastrointestinal Involvement 23
THE ROLE OF TH9 LYMPHOCYTES IN RHEUMATOID ARTHRITIS 23
null 22
EXPRESSION OF HERV-E CLONE 4.1 GAG TRANSCRIPTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 22
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 22
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection 22
Fibromialgia 21
The preventive and therapeutic role of physical activity in knee osteoarthritis 21
Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale 20
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 20
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 20
PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER 20
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 19
One year in review 2017: fibromyalgia. 19
null 19
null 18
Totale 3.805
Categoria #
all - tutte 19.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020510 7 3 1 12 13 72 202 37 10 63 62 28
2020/2021463 18 7 109 19 112 24 35 53 16 38 19 13
2021/2022666 5 38 17 27 43 17 42 33 14 36 35 359
2022/20231.895 148 195 124 153 71 192 34 105 796 11 49 17
2023/2024516 44 56 19 35 40 195 2 16 6 32 8 63
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 4.222